PENTOKEY ORGANY (INDIA) LTD.

Trades pharmaceutical products and, more recently, fertilizers and pesticides on BSE (Scrip Code 524210). FY26 revenue from operations came in at ₹209 lakh, up from ₹82.62 lakh in FY25, with the trading push reflected in H1 FY26 half-year revenue of ₹604.54 lakh before large sales returns or reversals in Q3 FY26 pulled quarterly revenue into negative territory. Net profit for FY26 was ₹20.32 lakh, down from ₹24.55 lakh the prior year, as employee costs of 7.7% of revenue and other operating expenses of 9.8% absorbed most of the trading margin. Materials and depreciation were reported at 0% of revenue, consistent with a pure trading model rather than any manufacturing activity. On the balance sheet, total equity stood at ₹969.52 lakh with cash and bank balances above ₹604 lakh and minimal debt, while trade receivables spiked to ₹675.98 lakh and trade payables rose to ₹453 lakh by H1 FY26 alongside the trading scale-up. The company has a small paid-up equity base of ₹627.26 lakh, a net worth of ₹915.72 lakh as of March 2025, and around 9,390 shareholders on record.